IP Library › Granted Patent US 12,280,216
Granted Patent B2
US 12,280,216 · App. 18/662,085 · Granted Apr 22, 2025

Mixtures including nitrous oxide

Inventor: Thomas E. Garrison (Scottsdale, AZ)
A61M16/12A61M16/06A61M2202/0283
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,280,216
App. No.
18/662,085
Granted
Apr 22, 2025
Kind
B2
Abstract

Apparatus for providing a mixture including nitrous oxide (N 2 O) to a subject are disclosed. One apparatus includes a first reservoir for storing a first gas including at least N 2 O and a mask connected to the first reservoir in which the mask includes a second reservoir integrated with the mask. The second reservoir is for storing a first additive and the mask is for combining the first gas and the first additive to create a mixture including at least the N 2 O and the first additive in the mask and introducing the mixture to the mouth and/or nose of a subject. Another apparatus includes a configuration including separate first and second reservoirs storing at least N 2 O and a first additive in which the first reservoir and/or the second reservoir are detachably connected to the mask.

Claims (58)

1. An apparatus, comprising:

a first reservoir configured to store a first gas, the first gas including at least nitrous oxide (N 2 O);

a mask directly coupled to the first reservoir, the mask comprising a second reservoir integrated with the mask; and

an actuator in communication with the first reservoir and the second reservoir,

wherein:

the second reservoir is configured to store a first additive,

the actuator is configured to release at least a portion of the first additive stored in the second reservoir into the mask and release at least a portion of the first gas stored in the first reservoir into the mask upon actuation, and

the mask is configured to:

combine the first gas and the first additive to create a mixture including at least the N 2 O and the first additive in the mask, and

introduce the mixture to one of a mouth of a subject, a nose of the subject, or both the mouth and the nose of the subject for inhalation by the subject.

2. The apparatus of claim 1 , wherein the first additive comprises one of a liquid, a second gas, a compressed gas, or a combination thereof.

3. The apparatus of claim 1 , wherein the first gas comprises a first predetermined percentage of the N 2 O in the range of 0.1% to 100% by volume.

4. The apparatus of claim 3 , wherein the first gas further comprises a second predetermined percentage of a second additive in the range of 0.1% to 99.9% by volume.

5. The apparatus of claim 1 , wherein the mixture comprises a predetermined percentage of the N 2 O in the range of 20% to 99% by volume.

6. The apparatus of claim 1 , wherein the first gas further comprises one of compressed air, pure oxygen (O 2 ), air, or atmospheric air.

7. The apparatus of claim 6 , wherein:

the first additive comprises one of water (H 2 O), hydrogen peroxide (H 2 O 2 ), a cannabis extract, an essential oil, an herbal extract, a supplement, a medication, a vitamin, caffeine, a silver, a flavoring, a nano-capacitor, or a nutrient;

the second reservoir is further configured to store a second additive;

the second additive comprises one of the compressed air, the O 2 , the air, the atmospheric air, the H 2 O, the H 2 O 2 , the cannabis extract, the essential oil, the herbal extract, the supplement, the medication, the vitamin, the caffeine, the silver, the flavoring, the nano-capacitor, or the nutrient; and

the second additive is different from the first additive.

8. The apparatus of claim 1 , wherein the first additive comprises one of water (H 2 O), hydrogen peroxide (H 2 O 2 ), a cannabis extract, an essential oil, an herbal extract, a supplement, a medication, a vitamin, caffeine, a silver, a flavoring, a nano-capacitor, or a nutrient.

9. The apparatus of claim 8 , wherein:

the second reservoir is further configured to store a second additive;

the second additive comprises one of the compressed air, the O 2 , the air, the atmospheric air, the H 2 O, the H 2 O 2 , the cannabis extract, the essential oil, the herbal extract, the supplement, the medication, the vitamin, the caffeine, the silver, the flavoring, the nano-capacitor, or the nutrient; and

the second additive is different from the first additive.

10. An apparatus, comprising:

a mask;

a first reservoir, the first reservoir storing a first gas including at least nitrous oxide (N 2 O);

a second reservoir, the second reservoir storing at least a first additive to the first gas; and

an actuator in communication with the first reservoir and the second reservoir,

wherein:

the first reservoir and the second reservoir are separate reservoirs,

the actuator is configured to release at least a portion of the first additive to the first gas stored in the second reservoir into the mask and release at least a portion of the first gas stored in the first reservoir into the mask upon actuation,

both the first reservoir and the second reservoir are directly coupleable to the mask, and

the mask is configured to:

combine the first gas and the first additive to create a mixture including at least the N 2 O and the first additive in the mask, and

introduce the mixture to one of a mouth of a subject, a nose of the subject, or both the mouth and the nose of the subject for inhalation by the subject.

11. The apparatus of claim 10 , wherein the first gas comprises a first predetermined percentage of the N 2 O in the range of 0.1% to 100% by volume.

12. The apparatus of claim 11 , wherein the first gas further comprises a second predetermined percentage of a second additive in the range of 0.1% to 99.9% by volume.

13. The apparatus of claim 10 , wherein the mixture comprises a predetermined percentage of the N 2 O in the range of 20% to 99% by volume.

14. The apparatus of claim 10 , wherein the first gas further comprises one of compressed air, pure oxygen (O 2 ), air, or atmospheric air.

15. The apparatus of claim 14 , wherein:

the first additive comprises one of water (H 2 O), hydrogen peroxide (H 2 O 2 ), a cannabis extract, an essential oil, an herbal extract, a supplement, a medication, a vitamin, caffeine, a silver, a flavoring, a nano-capacitor, or a nutrient;

the second reservoir is further configured to store a second additive;

the second additive comprises one of the compressed air, the O 2 , the air, the atmospheric air, the H 2 O, the H 2 O 2 , the cannabis extract, the essential oil, the herbal extract, the supplement, the medication, the vitamin, the caffeine, the silver, the flavoring, the nano-capacitor, or the nutrient; and

the second additive is different from the first additive.

16. The apparatus of claim 10 , wherein the first additive comprises one of water (H 2 O), hydrogen peroxide (H 2 O 2 ), a cannabis extract, an essential oil, an herbal extract, a supplement, a medication, a vitamin, caffeine, a silver, a flavoring, a nano-capacitor, or a nutrient.

17. The apparatus of claim 16 , wherein:

the second reservoir is further configured to store a second additive;

the second additive comprises one of the compressed air, the O 2 , the air, the atmospheric air, the H 2 O, the H 2 O 2 , the cannabis extract, the essential oil, the herbal extract, the supplement, the medication, the vitamin, the caffeine, the silver, the flavoring, the nano-capacitor, or the nutrient; and

the second additive is different from the first additive.

18. The apparatus of claim 10 , wherein both the first reservoir and the second reservoir are detachably coupleable to the mask.

19. The apparatus of claim 10 , wherein:

the first reservoir is detachably coupleable to the mask; and

the second reservoir is coupled to the mask.

20. The apparatus of claim 10 , wherein:

the second reservoir is detachably coupleable to the mask; and

the first reservoir is coupled to the mask.

Continuity (2)
Continuation In Part 18104540 · Feb 1, 2023
Related Publication 20240299694A1 · Sep 12, 2024
References Cited (21)
US 6221377B1 · Meyer · 2001 [cited by applicant]
US 9757528B2 · Rubin · 2017 [cited by applicant]
US 11065223B2 · Rosenblatt et al. · 2021 [cited by applicant]
US 11273274B1 · Schatz · 2022 [cited by examiner]
US 20030127102A1 · Strawder · 2003 [cited by examiner]
US 20080066741A1 · LeMahieu et al. · 2008 [cited by applicant]
US 20080173558A1 · Arvanitis · 2008 [cited by examiner]
US 20100163033A1 · Hyde et al. · 2010 [cited by applicant]
US 20120045528A1 · Bessiere et al. · 2012 [cited by applicant]
US 20190126096A1 · Squibb · 2019 [cited by applicant]
US 20190328699A1 · Forde · 2019 [cited by examiner]
US 20200197654A1 · Alizoti · 2020 [cited by examiner]
US 20230001128A1 · Shuster et al. · 2023 [cited by applicant]
US 20230285780A1 · Phillips-Reyes · 2023 [cited by examiner]
CN 103127165A · 2013 [cited by applicant]
WO 2021138602A1 · 2021 [cited by applicant]
WO 2022069690A2 · 2022 [cited by applicant]
Kalmoe et al., “Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents”, Mar. 14, 2020, Elsevier, All Pages (Year: 2020). [cited by examiner]
J. Jarry, “This Sticky Pain Patch's Science Hits a Sticky Patch”, Office for Science and Society (OSS), Sep. 23, 2022, pp. 1-7. [cited by applicant]
“Kailo Review: Targeted Pain Relief Patch Nanotech That Works—2021 Review”, 2021Review.com, Mach 11, 2021, pp. 1-8. [cited by applicant]
M.C. Kalmoe et al., “Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents”, Journal of the Neurological Sciences, Mar. 19, 2020, pp. 1-8. [cited by applicant]